Results of the FIH Surgery of the AGIBOT Laparoscopic Surgical Robot in Urology Made Public

Recently, the research results of the first-in-human (FIH) surgery of the AGIBOT Laparoscopic Surgical Robot independently developed by AGIBOT Medical Technology (Suzhou) Co., Ltd. (AGIBOT) were publicly released in the January 2024 issue of the ISTIC-indexed Journal of Minimally Invasive Urology.

This study was performed in December 2023 under the supervision of Professor Guo Hongqian, Director of Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, and the collaboration of Professor Xu Linfeng, Professor Liu Guangxiang, and Professor Zhang Shun. Three urological surgeries were successfully performed using the domestic AGIBOT Laparoscopic Surgical Robot, including two radical prostatectomies and one partial nephrectomy. The surgical difficulties in this study ranged from moderate to complex, including lesion resection and tissue reconstruction, sexual nerve preservation and other techniques. All surgeries were successfully completed according to the planned protocol, with no intraoperative transfer and no Clavien-Din-do grade ≥ I complications. The intraoperative indicators and postoperative results indicated that the surgical results were good, and the patients recovered well.

The results of the trial show that the AGIBOT Laparoscopic Surgical Robot developed by AGIBOT has demonstrated high feasibility and safety in FIH surgery, and can be safely and effectively applied to robot-assisted urological surgery.